Tuesday, September 20, 2022 at 9am EDT | 6am PDT | 2pm BST | 3pm CEST As clinical trial protocols become more complex, patient informed consent forms and processes become more complicated as well. In this webinar, IQVIA Complete Consent leaders will share how a robust eConsent solution can be customized to support these complex multi-stage studies and high-risk patient populations with an efficient customized, site- and participant-friendly consenting experience.
Register Free: http://www.appliedclinicaltrialsonline.com/act_w/complex_trials
Event Overview:
As clinical trial protocols become more complex, patient informed consent forms and processes become more complicated as well. Not only is it critical to effectively engage patients in the consenting process early to ensure protocol adherence and meet trial milestones, it’s essential that their consent be tracked from initial screening through cohort or treatment group assignment and each subsequent amendment.
A feature-rich electronic consent platform can provide an easy, secure way to deliver a highly engaging, regulatory compliant informed consent process that supports better study outcomes – especially in novel trial designs such as basket, umbrella, and platform trials.
In this webinar, IQVIA Complete Consent leaders will share how a robust eConsent solution can be customized to support these complex multi-stage studies and high-risk patient populations with an efficient customized, site- and participant-friendly consenting experience.
3 Key take-aways
Join IQVIA Technologies leaders to learn why eConsent is the ideal tool for:
Speakers
Karen Maduschke
Sr. Director & General Manager
Patient Consent at IQVIA
Karen Maduschke is recognized as a global expert in electronic informed consent for the healthcare industry. With more than 25 years of experience in the industry, Karen has been involved with eConsent from its earliest inception. During the pandemic, Karen led the rapid deployment of IQVIA Complete Consent for numerous COVID19 vaccine and treatment trials. She is an advocate for patient-centricity in clinical trials and improved transparency in the informed consent process.
Vinita Navadgi
Senior Director, Product and Strategy
Patient Consent at IQVIA
Vinita Navadgi is a technology leader focused on innovation in clinical research and advancement of drugs. With over 25 years of technology expertise, she is passionate about accelerating clinical research and the patient consenting process by leveraging digitally transformative technologies while offering intuitive user experiences.
Register Free: http://www.appliedclinicaltrialsonline.com/act_w/complex_trials